Get started
CCC

BIOCURE TECHNOLOGY INC.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

CURE chart

Key stats

Market capitalization
‪1.22 M‬CAD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
1.205
Basic EPS (TTM)
0.015CAD
Net income (FY)
‪−1.45 M‬CAD
Revenue (FY)
—
Shares float
‪60.62 M‬
Beta (1Y)
−0.49

About BIOCURE TECHNOLOGY INC.

Sector
Health Technology
Industry
Biotechnology
CEO
Sang-Mok Lee
Website
biocuretech.com
Headquarters
Vancouver
Founded
2007
FIGI
BBG000QW95B7
Biocure Technology, Inc. engages in the development and commercialization of biosimilar products. Its also offers CAR-T Cell immunotherapy, hair growth treatment, and FMD vaccine products. The company was founded on August 24, 2007 and is headquartered in Vancouver, Canada.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CURE is 0.015 CAD — it has decreased by 25.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on CSE exchange BIOCURE TECHNOLOGY INC. stocks are traded under the ticker CURE.
CURE stock is 33.33% volatile and has beta coefficient of −0.49. Check out the list of the most volatile stocks — is BIOCURE TECHNOLOGY INC. there?
Yes, you can track BIOCURE TECHNOLOGY INC. financials in yearly and quarterly reports right on TradingView.
CURE net income for the last quarter is ‪−113.16 K‬ CAD, while the quarter before that showed ‪2.62 M‬ CAD of net income which accounts for −104.32% change. Track more BIOCURE TECHNOLOGY INC. financial stats to get the full picture.
No, CURE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CURE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOCURE TECHNOLOGY INC. stock right from TradingView charts — choose your broker and connect to your account.
CURE reached its all-time high on Feb 1, 2018 with the price of 1.890 CAD, and its all-time low was 0.005 CAD and was reached on Apr 14, 2014.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOCURE TECHNOLOGY INC. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOCURE TECHNOLOGY INC. stock shows the sell signal. See more of BIOCURE TECHNOLOGY INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.